Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes

Neurology

Volumn 46, Issue 3, 1996, Pages 802-809

  Vila, M ^a   Herrero, M T ^c   Levy, R ^a   Faucheux, B ^a   Ruberg, M ^a   Guillen, J ^b   Luquin, M R ^b   Guridi, J ^b   Javoy Agid, F ^a   Agid, Y ^a   Obeso, J A ^b   Hirsch, E C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; LEVODOPA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DENERVATION; GABAERGIC SYSTEM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MONKEY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUPERIOR COLLICULUS;

EID: 9044247849     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.3.802     Document Type: Article

References (54)

1. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain functions. Pharm Rev 1966;18:925-964.
2. Yahr MD. Parkinson's disease: the L-dopa era. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y, eds. Advances in Neurology, vol. 60. New York: Raven, 1993.
3. Alexander GE, Crutcher MD. Functional architecture of the basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:226-271.
4. Wichmann T, DeLong MR. Pathophysiology of parkinsonian motor abnormalities. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y, eds. Advances in Neurology, vol. 60. New York: Raven, 1993.
5. Beckstead RM, Cruz CJ. Striatal axons to the globus pallidus, entopeduncular nucleus and substantia nigra come mainly from separate cell populations in cat. Neuroscience 1986;19: 147-158.
6. Deniau JM, Chevalier G. The lamellar organization of the rat substantia nigra pars reticulata: distribution of projection neurons. Neuroscience 1992;2:361-377.
7. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci 1990;13:254-258.
8. DiFiglia M, Aronin N, Leeman SE. Immunoreactive substance P in the substantia nigra of the monkey: light and electron microscopic localization. Brain Res 1981;233:381-388.
9. DiFiglia M, Aronin N, Martin JB. Light and electron microscopic localization of immunoreactive Leu-enkephalin in the monkey basal ganglia. J Neurosci 1982;2:303-320.
10. Haber SN, Elde RP. The distribution of enkephaline immunoreactive fibers and terminals in the monkey central nervous system: an immunohistochemical study. Neuroscience 1982;7: 1049-1095.
11. Ruffieux A, Schultz W. Dopaminergic activation in reticulata neurons in the substantia nigra. Nature 1980;285:240-241.
12. 3H] GABA release: an approach to the study of the regulation of GABA containing neurons in the basal ganglia and associated structures in the cat and rat. In: Neurochemical analysis of the conscious brain: voltammetry and push-pull perfusion. Ann N Y Acad Sci 1986;473:475-488.
13. Hikosaka O, Wurtz RH. Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus. J Neurophysiol 1983;49: 1285-1301.
14. Lestienne F, Caillier P. Role of the monkey substantia nigra pars reticulata in orienting behaviour and visually triggered arm movements. Neurosci Lett 1986;64:109-115.
15. Mugnaini E, Oertel WH. Atlas of distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T, eds. Handbook of chemical neuroanatomy, vol. 4. Amsterdam: Elsevier Science, 1985.
16. Chesselet MF, Mercugliano M, Soghomonian J-J, Salin P, Qin Y, Gonzales C. Regulation of glutamic acid decarboxylase gene expression in efferent neurons of the basal ganglia. Prog Brain Res 1993;99:143-154.
17. Luquin MR, Herrero MT, Obeso JA. Parkinsonismo inducido por MPTP como modelo experimental de Enfermedad de Parkinson. Neurologia 1992;31:551-554.
18. Levy R, Ruberg M, Herrero MT, et al. Alterations of GABAergic neurons in the basal ganglia of patients with supranuclear palsy. Neurology 1995;45:127-134.
19. Chesselet MF, Weiss L, Wuenschell C, Tobin AJ, Affolter HU. Comparative distribution of RNAs for glutamic acid decarboxylase, tyrosine hydroxylase and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J Comp Neurol 1987;262:125-140.
20. Bisconte JC, Fulcrand J, Marty R. Analyse radioautographique dans le système nerveux central par photométric et cartographie combinées. C R Soc Biol 1968;162:2178.
21. Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 1990;38:245-253.
22. François C, Percheron G, Yelnik J. Localization of nigrostriatal, nigrothalamic and nigrotactal neurons in ventricular coordinates in macaques. Neuroscience 1984;13:61-76.
23. Beckstead RM, Frankfurter A. The distribution and some morphological features of substantia nigra neurons that project to the thalamus, superior colliculus and pedunculopontine nucleus in the monkey. Neuroscience 1982;7:2377-2388.
24. Grantyn R. Gaze control through superior colliculus: structure and function. In: Bütner-Ennever, ed. Neuroanatomy of the oculomotor system. Amsterdam: Elsevier Science, 1988.
25. Graybiel AM, Ragsdale CW. Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc Natl Acad Sci USA 1978;75:5723-5726.
26. Bu DF, Erlander MG, Hitz BC, et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 1992;89:2115-2119.
27. 67 mRNA. Eur J Neurosci 1995;7:1199-1209.
28. Baran H, Lassman H, Hornykiewicz O. Behavioural and neurochemical changes 6 months after kainic acid. Soc Neurosci Abstr 1988;14:472.
29. Gale K, Casu M. Dynamic utilization of GABA in the substantia nigra: regulation by dopamine and GABA in the striatum and its clinical and behavioural implications. Mol Cell Biochem 1981;39:369-405.
30. Linderfors N, Brene S, Persson H. Increased expression of glutamic acid decarboxylase in rat substantia nigra after ibotenic acid lesion in the caudate-putamen. Mol Brain Res 1990; 7:207-212.
31. Marksteiner J, Sperk G. Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in frontal cortex of rats with decreased seizure threshold. Neuroscience 1988;26:379-385.
32. Herrero MT, Ruberg M, Hirsch EC, et al. Changes in GAD mRNA expression in neurons of the internal pallidum in parkinsonian monkeys after L-dopa therapy. Soc Neurosci Abstr 1993;19:132.
33. Fillion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142-151.
34. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993;60:395-407.
35. Waszczak BL, Walters JR. A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 1984;105:369-373.
36. Bowen DM, Smith CB, White P, et al. Chemical pathology of organic dementias. I. Validity of biochemical measurements on human post-mortem brain specimens. Brain 1977;100:397-426.
37. Montfort JC, Javoy-Agid F, Hauw J-J, Dubois B, Agid Y. Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain 1985;108:301-313.
38. Perry EK, Perry RH, Tomlinson BE. The influence of agonal status on some neurochemical activities of post-mortem human brain tissue. Neurosci Lett 1982;29:303-307.
39. Perry EK, Perry RH. Human brain neurochemistry - some postmortem problems. Life Sci 1983;33:1733-1743.
40. Guridi J, Luquin MR, Herrero MT, Obeso JA. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord 1993;8:421-429.
41. Guridi J, Herrero MT, Ruberg M, et al. Decreased GAD mRNA expression in internal pallidum and substantia nigra pars reticulata after subthalamotomy in MPTP-treated monkeys. Soc Neurosci Abstr 1993;19:133.
42. Hikosaka O, Wurtz RH. Visual and oculomotor functions of monkey substantia nigra pars reticulata. I. Relation of visual and auditory responses to saccades. J Neurophysiol 1983;49: 1230-1253.
43. Hikosaka O, Wurtz RH. Visual and oculomotor functions of monkey substantia nigra pars reticulata. II. Visual responses related to fixation of gaze. J Neurophysiol 1983;49:1254-1267.
44. Hikosaka O, Wurtz RH. Visual and oculomotor functions of monkey substantia nigra pars reticulata. III. Memory-contingent visual and saccade responses. J Neurophysiol 1983;49: 1268-1284.
45. Hikosaka O, Wurtz RH. The basal ganglia. In: Wurtz and Goldberg, eds. The neurobiology of saccadic eye movements. Amsterdam: Elsevier Science, 1989.
46. Usui S, Fukuda H, Hikosaka O. Spontaneous saccades in MPTP-induced hemi-parkinsonian monkeys. Clin Neurol 1990;30:1181-1189.
47. Dubois B, Boller F, Pillon B, Agid Y. Cognitive deficits in Parkinson's disease. In: Boller F, Grafman J, eds. Handbook of neuropsychology, vol. 5. Amsterdam: Elsevier Science, 1991:195-240.
48. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986;9:357-381.
49. Beninato M, Spencer R. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res 1987;412:169-174.
50. Hirsch EC, Graybiel AM, Duyckaerts Ch, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 1987;84:5976-5980.
51. Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988;51:540-543.
52. Herrero MT, Hirsch EC, Javoy-Agid Y, Obeso JA, Agid Y. Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum. Brain Res 1993;624:281-285.
53. Vermersch A-I, Rivaud S, Vidailhet M, et al. Sequences of memory-guided saccades in Parkinson's disease. Ann Neurol 1994;35:487-490.
54. Lu SM, Lin CS, Behan M, Cant MB, Hall WC. Glutamate decarboxylase immunoreactivity in the intermediate gray layer of the superior colliculus in the cat. Neuroscience 1985; 16:123-131.